Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab
Clinical trial NCT00609869 · COMPLETED
Trial details
- NCT number
- NCT00609869
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2014-02-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.